Combination Product: Daratumumab Lenalidomide Dexamethasone For 24 Months: 1 Clinical Trial

Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Condition(s):Multiple Myeloma in RelapseLast Updated:March 1, 2023Active, not recruiting

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.